Table 2.

Univariate Analyses of the Associations with Long-Term Mortality (N=2727)

Variable	Survived N (%)	Died N (%)	P-Value
Overall Survival	1226 (45.0)	1501 (55.0)	<0.01
Sociodemographic:
Male	1203 (44.1)	1484 (54.4)	0.1
Age Group:
<60 years	550 (20.2)	579 (21.2)	<0.01
60–70 years	471 (17.3)	647 (23.7)	0.01
70–80 years	97 (3.6)	141 (5.2)	0.17
80–90 years	2 (0.07)	3 (0.11)	0.82
90–100 years	1 (0.04)	1 (0.04)	0.88
Race:
White	942 (34.5)	1115 (40.9)	0.12
Black	228 (8.4)	307 (11.3)	0.23
Hispanic	83 (3.0)	115 (4.2)	0.37
Other	56 (2.1)	79 (2.9)	0.41
Married	642 (23.5)	742 (27.2)	0.13
Smoking Cessation	383 (14.0)	422 (15.5)	0.08
Alcohol Abuse	51 (1.9)	68 (2.5)	0.64
Drug Abuse	17 (0.62)	15 (0.55)	0.35
VA Priority Group:
1	205 (7.5)	264 (9.7)	0.55
2–6	898 (32.9)	1124 (41.2)	0.33
7–8	120 (4.4)	112 (4.1)	0.03
Comorbid Conditions:
Myocardial Infarction	104 (3.8)	158 (5.8)	0.07
Congestive Heart Failure	253 (9.3)	460 (16.9)	<0.01
Peripheral Vascular Disease	210 (7.7)	332 (12.2)	<0.01
COPD	324 (11.9)	471 (17.3)	<0.01
Rheumatic Fever	35 (1.3)	40 (1.5)	0.76
Cirrhosis	12 (0.44)	27 (0.99)	0.07
Dementia	35 (1.3)	76 (2.8)	<0.01
Diabetes (without complications)	533 (19.5)	657 (24.1)	0.88
Diabetes (with complications)	192 (7.0)	293 (10.7)	<0.01
Hepatitis	6 (0.22)	13 (0.48)	0.24
Paraplegia	33 (1.2)	52 (1.9)	0.25
Renal Disease	319 (11.7)	450 (16.5)	0.02
Cancer	283 (10.4)	410 (15.0)	0.01
Metastatic Cancer	42 (1.5)	85 (3.1)	<0.01
AIDS	4 (0.15)	7 (0.26)	0.56
Number of Medications by type:*
Diabetes	.43 (.02)	.41 (.02)	0.28
Pulmonary	.50 (.04)	.63 (.04)	0.99
Cardiac	1.9 (.05)	1.8 (.05)	0.04
Oral	.26 (.02)	.26 (.02)	0.50

Table shows outcomes as total number and percentage or mean and standard deviation

^*Includes medications given 90 days prior to admission.